Patent application number | Description | Published |
20090265049 | AIRCRAFT SYSTEM EMISSIONS AND NOISE ESTIMATION MECHANISM - A method for generating emissions estimations of an aircraft is provided. A plurality of aircraft parameters is gathered. A first parameter of the plurality of aircraft parameters is selected for a first model. The first model mathematically contributes to the formulation of a first emissions estimation. The first model is considered with a plurality of additional models in view of the plurality of aircraft parameters to obtain the first emissions estimation. The first emissions estimation is a composite representation of the first model and the plurality of additional models in view of the plurality of aircraft parameters. | 10-22-2009 |
20100271239 | Method for compiling and displaying atmospheric uncertainty information - A method of displaying on a display ( | 10-28-2010 |
20100274542 | ENHANCED PREDICTION OF ATMOSPHERIC PARAMETERS - A method and software program for providing a weather prediction of atmospheric parameters for an aircraft, includes collecting ( | 10-28-2010 |
20110270470 | AIRCRAFT SYSTEMS AND METHODS WITH ACTIVE DECELERATION CONTROL - A system is provided for controlling the speed of an aircraft during a deceleration segment between a first state associated with a first speed and a first time and a second state associated with a second speed and a second time. The system includes a navigation system configured to determine the first state; a guidance system configured to determine the second state; and an active deceleration system coupled to the navigation system and the guidance system and configured to construct the deceleration segment between the first state and the second state with at least one intermediate speed between the first speed and the second speed. | 11-03-2011 |
20120059535 | SYSTEMS AND METHODS FOR RTA CONTROL OF MULTI-SEGMENT FLIGHT PLANS WITH SMOOTH TRANSITIONS - Methods, systems and device are provided for smoothing a required time of arrival (RTA) speed transition for an aircraft in a multi-segmented speed profile including at least one preceding region with a first predetermined speed pad and at a speed constrained region with a second predetermined speed pad. Exemplary methods include, but are not limited to determining whether a speed constrained region is engaged by a preceding region based at least in part on a speed of an aircraft. If the speed constrained region is engaged, the instructions determine a revised second speed pad for the speed constrained region. If the speed constrained region is not engaged then the instructions assign a default speed pad as the second speed pad for the speed constrained region. The instructions also compile a new speed profile that is defined by one of the revised second speed pad and the default speed pad for the speed constrained region and transmit commands that accelerate the aircraft to a new speed based on the new speed profile. | 03-08-2012 |
20140278069 | METHODS AND SYSTEMS FOR REPRESENTING TIME OF ARRIVAL INFORMATION ON A COCKPIT DISPLAY - A method is provided for displaying information on a display device of an aircraft. The method comprises receiving data indicating a point selected from a trajectory of a flight path; determining an estimated time of arrival minimum and an estimated time of arrival maximum based on the point; and displaying in a dialogue box associated with the trajectory of the flight path the estimated time of arrival minimum and the estimated time of arrival maximum for the point. | 09-18-2014 |
Patent application number | Description | Published |
20080233187 | Method of Production of Fine-Crystalline Mixture Containing Non-Steroid Anti-Inflammatory Drug, Fine-Crystalline Mixture Obtainable by this Method and Solid Pharmaceutical Composition Containing this Mixture - The invention concerns a method of production of a fine-crystalline mixture containing a non-steroid anti-inflammatory drug and an auxiliary substance, wherein a coarse-crystalline substance from the group of non-steroid anti-inflammatory drugs is dissolved in a solvent at an increased temperature, the solution is subsequently distributed at rapid chilling into a cooling liquid containing the auxiliary substance, said cooling liquid being placed in an ice bath, and the product is then filtered off and dried. It further concerns the fine-crystalline mixture of the non-steroid anti-inflammatory drug and the auxiliary substance that can be obtained by the said method. The invention further concerns a solid pharmaceutical composition, having substantially improved dissolution properties, which contains 60 to 78% w/w of the fine-crystalline mixture, 17 to 40% w/w of microcrystalline cellulose, colloidal silicon dioxide in an amount of up to 0.3% w/w, a disintegrant in an amount of up to 4% w/w and optionally a surface active compound in an amount of up to 0.1% w/w. This solid pharmaceutical composition can be filled into capsules or used for the preparation of tablets. | 09-25-2008 |
20090032248 | METHOD FOR PRODUCTION, SUBSTITUTION, OR MINING OF GAS HYDRATE - A gas hydrate is produced by injecting guest molecules into voids in a layer of which temperature and pressure condition allows the guest molecules to cause to form hydrate, in a form of emulsion where liquid of the guest molecules is dispersed in water as minute particles having a size of less than a size of voids, and thereby dispersing the guest molecules uniformly into the voids in the layer. | 02-05-2009 |
20090156660 | PHARMACEUTICAL COMPOSITION CONTAINING TAXANE DERIVATIVE DESTINED FOR THE PREPARATION OF AN INFUSION SOLUTION, METHOD OF PREPARATION THEREOF AND USE THEREOF - A pharmaceutical composition containing a taxane derivative, destined for the preparation of an infusion solution for administration to patients, containing a concentrate consisting of a pharmaceutically effective amount of docetaxel, a suitable solvent, which is preferably ethanol, a surfactant, which is polysorbate 80 and a pharmaceutically effective amount of an appropriate buffer; and optionally a co-solvent, consisting of an aqueous solution of a pharmaceutically effective amount of polysorbate 80 and optionally suitable organic solvent and/or a pharmaceutically effective amount of an appropriate buffer. This composition shows an excellent chemical and physical stability. The invention includes also a method of preparation of the pharmaceutical composition and the use thereof. | 06-18-2009 |
20090318719 | METHOD OF PREPARATION AND ISOLATION OF BETULIN DIACETATE FROM BIRCH BARK FROM PAPER MILLS AND ITS OPTIONAL PROCESSING TO BETULIN - The invention relates to a method of preparation and isolation of betulin diacetate from birch bark from paper mills and its optional processing to betulin, wherein the birch bark is ground, mixed with two- to twenty-fold excess volume of water and is stirred so that all birch bark is dipped, then the fraction of the birch bark which floats on the surface is collected, said collected fraction is dried at the temperature in the range of from 50 to 85° C. and the betulin contained in the dried birch bark is then subjected to an acetylation reaction, after the acetylation the birch bark is dried at the temperature of from 50 to 100° C. and the formed betulin diacetate is then isolated from the birch bark by supercritical extraction of the birch bark with carbon dioxide at the pressure of 28-35 MPa and the temperature of from 50 to 100° C. and subsequently, the supercritical extract is recrystallized for direct use or for further processing. The further processing can be basic hydrolysis of the re-crystallized betulin diacetate to betulin. | 12-24-2009 |
20090325919 | METHOD OF PREPARATION OF A SOLUBLE FORMULATION OF WATER-INSOLUBLE PENTACYCLIC AND TETRACYCLIC TERPENOIDS, A SOLUBLE FORMULATION OF A PENTACYCLIC OR TETRACYCLIC TERPENOID AND A PHARMACEUTICAL COMPOSITION CONTAINING THIS SOLUBLE FORMULATION - The invention relates to a method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, wherein the water-insoluble terpenoid having a free carboxylic, hydroxy or amino functional group is derivatized on this functional group with a substituent selected from the group comprising substituents of general formula Xa bound to the hydroxy group of the terpenoid, wherein Xa is —OC—R—COOH, substituents of general formula Xa bound to the amino group of the terpenoid, wherein Xa is —OC—R—COOH, quarternary ammonium substituents of general formula Xb bound to the carboxy group of the terpenoid, wherein Xb is —(CH2)nN+R3Y—, quarternary ammonium substituents of general formula Xc bound to the carboxy group of the terpenoid, wherein Xc je —(CH2)nR+Y—, substituents of general formula Xd bound to the carboxy group of the terpenoid, wherein Xd represents —R—COOH, glycosylic substituents Xe bound by alpha or beta glycosidic bond to the hydroxy group or to the carboxy group of the terpenoid, wherein Xe is selected from the group comprising glucosyl, galactosyl, arabinosyl, rhamnosyl, lactosyl, cellobiosyl, maltosyl and the 2-deoxyanalogues thereof, and subsequently, the prepared derivative is dissolved in the solution containing water, a cyclodextrin and optionally pharmaceutically acceptable auxiliary substances, forming an inclusion derivative with the cyclodextrin. Object of the invention is further a soluble formulation of a pentacyclic or tetracyclic triterpenoid, containing an inclusion complex of the derivatized pentacyclic or tetracyclic terpenoid with a cyclodextrin, and optionally water and pharmaceutically acceptable auxiliary substances and further a pharmaceutical composition containing the soluble formulation. | 12-31-2009 |